These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27878663)

  • 21. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
    Welzel D; Hull R; Fareed J
    Int Angiol; 2011 Jun; 30(3):199-211. PubMed ID: 21617603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Survey of current status of prevention of venous thromboembolism after thoracic surgery in China].
    Song CF; Li H; Tian B; Chen S; Miao JB; Fu YL; You B; Hu B
    Zhonghua Wai Ke Za Zhi; 2017 Sep; 55(9):661-666. PubMed ID: 28870050
    [No Abstract]   [Full Text] [Related]  

  • 23. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
    Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
    J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended therapy for primary and secondary prevention of venous thromboembolism.
    Conway SE; Marcy TR
    J Pharm Pract; 2010 Aug; 23(4):313-23. PubMed ID: 21507831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery?
    Squizzato A; Romualdi E; Dentali F; Ageno W
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):722-5. PubMed ID: 20847691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of venous thromboembolism prophylaxis with fondaparinux in ischemic stroke.
    Hackett CT; Ramanathan RS; Malhotra K; Quigley MR; Kelly KM; Tian M; Protetch J; Wong C; Wright DG; Tayal AH
    Thromb Res; 2015 Feb; 135(2):249-54. PubMed ID: 25554497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombosis in the setting of cancer.
    Streiff MB
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):196-205. PubMed ID: 27913480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of venous thromboembolism in the geriatric patient.
    Brotman DJ; Jaffer AK
    Cardiol Clin; 2008 May; 26(2):221-34, vi. PubMed ID: 18406996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do palliative physicians manage venous thromboembolism?
    Johnson MJ; Sherry K
    Palliat Med; 1997 Nov; 11(6):462-8. PubMed ID: 9519169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chest physicians' knowledge of appropriate thromboprophylaxis: insights from the PROMOTE study.
    Bikdeli B; Sharif-Kashani B; Raeissi S; Ehteshami-Afshar S; Behzadnia N; Masjedi MR
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):667-72. PubMed ID: 21986466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of thromboprophylaxis management in patients with major trauma.
    Imberti D; Ageno W
    Pathophysiol Haemost Thromb; 2005; 34(6):249-54. PubMed ID: 16772735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
    Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
    Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prevention of Venous Thromboembolism in Surgical Patients.
    Hansrani V; Khanbhai M; McCollum C
    Adv Exp Med Biol; 2017; 906():1-8. PubMed ID: 27620304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Korean guidelines for the prevention of venous thromboembolism.
    Bang SM; Jang MJ; Oh D; Kim YK; Kim IH; Yoon SS; Yoon HJ; Kim CS; Park S;
    J Korean Med Sci; 2010 Nov; 25(11):1553-9. PubMed ID: 21060742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion.
    Haines ST; Dager WE; Trujillo TC
    Am J Health Syst Pharm; 2010 May; 67(10 Suppl 6):S26-30. PubMed ID: 20479089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series study.
    Vitale FV; Rotondo S; Sessa E; Parisi A; Giaimo V; D'Angelo A; Antonelli G; Romeo P; Ferraù F
    J Oncol Pharm Pract; 2012 Mar; 18(1):10-6. PubMed ID: 21228085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended anticoagulation therapy for the primary and secondary prevention of venous thromboembolism.
    Blanchard E; Ansell J
    Drugs; 2005; 65(3):303-11. PubMed ID: 15669876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.